CN Patent

CN105131003B — 6,7‑不饱和‑7‑氨基甲酰基吗啡喃衍生物的晶体及其制备方法

Assigned to Shionogi and Co Ltd · Expires 2017-09-26 · 9y expired

What this patent protects

6,7‑不饱和‑7‑氨基甲酰基吗啡喃衍生物的晶体及其制备方法。本发明提供了式(IA)表示的化合物的稳定晶形： 其酸加成盐和/或其溶剂合物。特别地，所述晶形可用作制备药物的材料。本发明还提供了制备6,7‑不饱和‑7‑氨基甲酰基吗啡喃衍生物的新方法。

USPTO Abstract

6,7‑不饱和‑7‑氨基甲酰基吗啡喃衍生物的晶体及其制备方法。本发明提供了式(IA)表示的化合物的稳定晶形： 其酸加成盐和/或其溶剂合物。特别地，所述晶形可用作制备药物的材料。本发明还提供了制备6,7‑不饱和‑7‑氨基甲酰基吗啡喃衍生物的新方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN105131003B
Jurisdiction
CN
Classification
—
Expires
2017-09-26
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.